THE CONAFAY GROUP, LLC

Lobbying for CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP · Representing the voice of emerging antibiotics industry

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · North Carolina · House · Senate · $60,000.00 income · posted Jul 18, 2025

Lobbying activity 1

Health Issues

Legislation related to antimicrobial resistance(AMR), reimbursement reform, CURES Act 2.0 and FY26 Appropriations and PAHPA.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.